MarketCap
Facebook
X
TelegramQuarterly report 2022-Q2
added 08-08-2022
Global Blood Therapeutics Long Term Debt Current 2011-2026 | GBT
Annual Long Term Debt Current Global Blood Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 5.67 M | 4.84 M | 1.87 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.67 M | 1.87 M | 4.12 M |
Long Term Debt Current of other stocks in the Biotechnology industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aptorum Group Limited
APM
|
433 K | $ 0.82 | 1.9 % | $ 4.47 M |  China |
 |
Aquestive Therapeutics
AQST
|
510 K | $ 4.18 | 2.32 % | $ 363 M |  USA |
 |
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
213 K | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M |  Canada |
 |
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | USA |
 |
AgeX Therapeutics
AGE
|
428 K | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
410 K | - | 1.93 % | $ 17.4 M | USA |
 |
argenx SE
ARGX
|
6.53 M | $ 832.14 | -0.97 % | $ 25 B |  Niderland |
 |
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | China |
 |
Ascendis Pharma A/S
ASND
|
14.2 M | $ 232.76 | -0.95 % | $ 5 B |  Danmark |
 |
Albireo Pharma
ALBO
|
3.08 M | - | -0.23 % | $ 916 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
317 K | - | 3.16 % | $ 1.9 M | USA |
 |
AlloVir
ALVR
|
10.8 M | - | 4.14 % | $ 49.1 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
57.6 K | $ 3.34 | 0.27 % | $ 8.04 B |  Australia |
 |
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
274 K | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | USA |
 |
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | USA |
 |
Atea Pharmaceuticals
AVIR
|
800 K | $ 4.59 | -1.4 % | $ 387 M | USA |
 |
Acer Therapeutics
ACER
|
104 K | - | 2.71 % | $ 14 M | USA |
 |
Aravive
ARAV
|
2.2 M | - | -13.39 % | $ 1.45 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | USA |
 |
Axsome Therapeutics
AXSM
|
434 K | $ 165.2 | -2.79 % | $ 8.22 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
419 K | - | - | $ 7.46 M |  Israel |
 |
Atreca
BCEL
|
3.54 M | - | -11.76 % | $ 5.79 M | USA |
 |
Alpine Immune Sciences
ALPN
|
756 K | - | - | $ 2.17 B | USA |
 |
BioVie
BIVI
|
74.5 K | $ 1.25 | 0.1 % | $ 1.85 M | USA |
 |
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
17.6 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biogen
BIIB
|
80.4 M | $ 190.58 | -2.33 % | $ 27.9 B | USA |
 |
BioMarin Pharmaceutical
BMRN
|
7.23 M | $ 61.56 | -1.7 % | $ 11.7 B | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
11 M | - | -9.72 % | $ 5.89 M | USA |
 |
Baudax Bio
BXRX
|
5.6 M | - | 0.59 % | $ 63 K | USA |
 |
Aptose Biosciences
APTO
|
428 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
337 K | - | -39.0 % | $ 4.57 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
538 K | - | 17.91 % | $ 11.1 M | USA |
 |
BioNTech SE
BNTX
|
39.5 M | $ 111.01 | 0.11 % | $ 27.2 B | Germany |
 |
Amneal Pharmaceuticals
AMRX
|
224 M | $ 14.68 | 0.1 % | $ 4.54 B | USA |
 |
Capricor Therapeutics
CAPR
|
749 K | $ 28.39 | 1.72 % | $ 760 M | USA |
 |
CASI Pharmaceuticals
CASI
|
1.06 M | $ 0.35 | -55.89 % | $ 47.6 M | USA |